Meihao Medical Group Co., Ltd.

As of December 31, 2024, Meihao Medical Group Co., Ltd. carries a market capitalization of 222.10M, placing it among publicly traded companies globally. Its enterprise value stands at 175.27M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Meihao Medical Group Co., Ltd. has 600.15M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Meihao Medical Group Co., Ltd. maintains a current ratio of 2.45, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Meihao Medical Group Co., Ltd.'s stock has gained approximately 34.29% over the past 52 weeks. The 50-day moving average sits at 0.54, while the 200-day moving average is 0.44.

As of December 31, 2024, Meihao Medical Group Co., Ltd. holds 83.53M in cash and equivalents against 35.58M in total debt, resulting in a net debt position of -83.53M. Total book value stands at 127.00M, with working capital of 61.89M providing operational flexibility.